Cafico Trust Co Ltd - Oct 31, 2023 Form 3 Insider Report for Mural Oncology plc (MURA)

Role: 10%+ Owner
Signature: /s/ Mairead Lyons
Stock symbol: MURA
Transactions as of: Oct 31, 2023
Transactions value $: $0
Form type: 3
Date filed: 11/7/2023, 04:18 PM

Transactions Table

Type	Sym	Class	Shares After	Date	Ownership	Footnotes
holding	MURA	Ordinary Shares, nominal value $1.00 per share	2	Oct 31, 2023	Direct	F1
holding	MURA	Euro Deferred Shares, nominal value 1.00 Euro per share	25K	Oct 31, 2023	Direct	F2
holding	MURA	Preferred Share, nominal value $0.01 per share	1	Oct 31, 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The ordinary shares of Mural Oncology plc ("Mural"), nominal value $1.00 per share, beneficially owned by Cafico Trust Company Limited, constitute 100% of the ordinary shares of Mural. As of the date of this report, Alkermes plc ("Alkermes") has announced its intention to separate its oncology business from the rest of Alkermes by means of a declaration of a dividend in specie, to be effected by the transfer of the oncology business from Alkermes to Mural and the issuance by Mural of ordinary shares to Alkermes shareholders.
F2	In connection with the separation of the oncology business, Cafico Trust Company Limited also owns (i) 25,000 Euro deferred shares, nominal value 1.00 Euro per share, and (ii) one preferred share, nominal value $0.01, of Mural.

Content

The ordinary shares of Mural Oncology plc ("Mural"), nominal value $1.00 per share, beneficially owned by Cafico Trust Company Limited, constitute 100% of the ordinary shares of Mural. As of the date of this report, Alkermes plc ("Alkermes") has announced its intention to separate its oncology business from the rest of Alkermes by means of a declaration of a dividend in specie, to be effected by the transfer of the oncology business from Alkermes to Mural and the issuance by Mural of ordinary shares to Alkermes shareholders.

In connection with the separation of the oncology business, Cafico Trust Company Limited also owns (i) 25,000 Euro deferred shares, nominal value 1.00 Euro per share, and (ii) one preferred share, nominal value $0.01, of Mural.